March 11, 2020 11:01 AM EDT

Bristol Myers scores new FDA nod for Opdivo/Yervoy combo; US Army wants Gilead's potential Covid-19 drug for infected troops

→ Bristol Myers Squibb has added one more type of cancer that its Opdivo/Yervoy combo is approved to treat, scoring an

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Bris­tol My­ers scores new FDA nod for Op­di­vo/Yer­voy com­bo; US Army wants Gilead­'s po­ten­tial Covid-19 drug for in­fect­ed troops